Paris - Delayed Quote EUR

Ipsen S.A. (IPN.PA)

112.50 +4.10 (+3.78%)
As of April 22 at 5:36 PM GMT+2. Market Open.
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
3,306,400.00
3,306,400.00
3,156,500.00
2,748,700.00
2,686,100.00
Cost of Revenue
571,200.00
571,200.00
527,700.00
438,600.00
490,600.00
Gross Profit
2,735,200.00
2,735,200.00
2,628,800.00
2,310,100.00
2,195,500.00
Operating Expense
2,144,900.00
2,144,900.00
1,757,500.00
1,456,600.00
1,471,300.00
Operating Income
590,300.00
590,300.00
871,300.00
853,500.00
724,200.00
Net Non Operating Interest Income Expense
-54,500.00
-54,500.00
-24,000.00
-31,300.00
-40,500.00
Pretax Income
761,500.00
761,500.00
706,100.00
789,200.00
532,400.00
Tax Provision
136,200.00
136,200.00
112,300.00
158,300.00
-17,800.00
Net Income Common Stockholders
644,400.00
644,400.00
648,600.00
646,600.00
548,000.00
Diluted NI Available to Com Stockholders
644,400.00
644,400.00
648,600.00
646,600.00
548,000.00
Basic EPS
7.79
7.79
7.87
7.82
6.61
Diluted EPS
7.73
7.73
7.81
7.76
6.57
Basic Average Shares
82,721.44
82,721.44
82,414.23
82,647.36
82,964.84
Diluted Average Shares
83,363.52
83,363.52
83,047.38
83,358.43
83,448.11
Total Operating Income as Reported
816,000.00
816,000.00
729,900.00
824,700.00
524,800.00
Total Expenses
2,716,100.00
2,716,100.00
2,285,200.00
1,895,200.00
1,961,900.00
Net Income from Continuing & Discontinued Operation
644,400.00
644,400.00
648,600.00
646,600.00
548,000.00
Normalized Income
435,185.80
435,185.80
706,866.00
658,266.00
665,288.00
Interest Income
--
--
500.00
100.00
2,300.00
Interest Expense
19,400.00
19,400.00
18,500.00
23,700.00
27,500.00
Net Interest Income
-54,500.00
-54,500.00
-24,000.00
-31,300.00
-40,500.00
EBIT
780,900.00
780,900.00
724,600.00
812,900.00
559,900.00
EBITDA
868,800.00
868,800.00
1,061,100.00
1,059,300.00
794,600.00
Reconciled Cost of Revenue
571,200.00
571,200.00
527,700.00
438,600.00
490,600.00
Reconciled Depreciation
87,900.00
87,900.00
336,500.00
246,400.00
234,700.00
Net Income from Continuing Operation Net Minority Interest
617,100.00
617,100.00
593,200.00
631,100.00
548,000.00
Total Unusual Items Excluding Goodwill
225,700.00
225,700.00
-141,200.00
-34,000.00
-162,900.00
Total Unusual Items
225,700.00
225,700.00
-141,200.00
-34,000.00
-162,900.00
Normalized EBITDA
643,100.00
643,100.00
1,202,300.00
1,093,300.00
957,500.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
43,785.80
43,785.80
-27,534.00
-6,834.00
-45,612.00
12/31/2020 - 12/7/2005

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

VETO.PA Vetoquinol SA
97.70
+1.66%
 
EAPI.PA Euroapi S.A.
2.7500
+2.54%
 
SOBI.ST Swedish Orphan Biovitrum AB (publ)
262.80
0.00%
 
HLUN-B.CO H. Lundbeck A/S
32.92
-0.24%
 
HIK.L Hikma Pharmaceuticals PLC
1,818.00
+1.06%
 
PCRX Pacira BioSciences, Inc.
26.10
-0.57%
 
COLL Collegium Pharmaceutical, Inc.
34.74
-0.29%
 
ALKS Alkermes plc
24.07
+0.92%
 
IRWD Ironwood Pharmaceuticals, Inc.
8.06
+1.77%
 
PRGO Perrigo Company plc
30.06
-2.40%